Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression
出版年份 2017 全文链接
标题
Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-07-19
DOI
10.1038/s41598-017-06844-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease
- (2017) Ton J. Rabelink et al. Nature Reviews Nephrology
- Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis
- (2016) Marjolein Garsen et al. AMERICAN JOURNAL OF PATHOLOGY
- Hyperoside ameliorates glomerulosclerosis in diabetic nephropathy by downregulating miR-21
- (2016) Le Zhang et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy
- (2016) Margien G.S. Boels et al. DIABETES
- Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis
- (2016) Nektaria Papadopoulou-Marketou et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update
- (2016) Niloy Bhattacharjee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury
- (2016) Jisheng Zhang et al. Journal of Natural Medicines
- Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx
- (2016) M. Garsen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cathepsin L is crucial for the development of early experimental diabetic nephropathy
- (2016) Marjolein Garsen et al. KIDNEY INTERNATIONAL
- Protective effects of hyperoside against H2O2-induced apoptosis in human umbilical vein endothelial cells
- (2016) XU-LIANG HAO et al. Molecular Medicine Reports
- Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte
- (2015) Marjolein Garsen et al. JOURNAL OF PATHOLOGY
- Hyperoside induces apoptosis and inhibits growth in pancreatic cancer via Bcl-2 family and NF-κB signaling pathway both in vitro and in vivo
- (2015) Yilong Li et al. TUMOR BIOLOGY
- Role of Heparanase-Driven Inflammatory Cascade in Pathogenesis of Diabetic Nephropathy
- (2014) R. Goldberg et al. DIABETES
- Diabetic Kidney Disease: A Report From an ADA Consensus Conference
- (2014) Katherine R. Tuttle et al. DIABETES CARE
- Anti-Inflammatory Effects of Hyperoside in Human Endothelial Cells and in Mice
- (2014) Sae-Kwang Ku et al. INFLAMMATION
- Hyperoside Inhibits High-Glucose-Induced Vascular Inflammation In Vitro and In Vivo
- (2014) Sae-Kwang Ku et al. INFLAMMATION
- Heparanase mediates renal injury
- (2014) Peter Sidaway Nature Reviews Nephrology
- The effect of hyperoside on the functional recovery of the ischemic/reperfused isolated rat heart: Potential involvement of the extracellular signal-regulated kinase 1/2 signaling pathway
- (2013) Zi-lin Li et al. FREE RADICAL BIOLOGY AND MEDICINE
- The glomerular basement membrane as a barrier to albumin
- (2013) Jung Hee Suh et al. Nature Reviews Nephrology
- The role of heparanase and the endothelial glycocalyx in the development of proteinuria
- (2013) Marjolein Garsen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Inflammation and Oxidative Stress in Diabetic Nephropathy: New Insights on Its Inhibition as New Therapeutic Targets
- (2013) Akira Mima Journal of Diabetes Research
- Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus
- (2012) Steven G. Coca et al. ARCHIVES OF INTERNAL MEDICINE
- Hyperoside protects cortical neurons from oxygen–glucose deprivation–reperfusion induced injury via nitric oxide signal pathway
- (2012) Rui-Li Liu et al. BRAIN RESEARCH
- Clinical implications of pathologic diagnosis and classification for diabetic nephropathy
- (2012) Se Won Oh et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The glomerular basement membrane
- (2012) Jeffrey H. Miner EXPERIMENTAL CELL RESEARCH
- Diabetic Nephropathy and Extracellular Matrix
- (2012) S. O. Kolset et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Pretreatment with the Total Flavone Glycosides of Flos Abelmoschus manihot and Hyperoside Prevents Glomerular Podocyte Apoptosis in Streptozotocin-Induced Diabetic Nephropathy
- (2012) Lei Zhou et al. JOURNAL OF MEDICINAL FOOD
- Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury
- (2012) Yanggang Yuan et al. KIDNEY INTERNATIONAL
- Clinical impact of albuminuria in diabetic nephropathy
- (2011) Takashi Wada et al. Clinical and Experimental Nephrology
- Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice
- (2011) N. Gil et al. DIABETES
- Reno-protective effects of renin–angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis
- (2011) P. Vejakama et al. DIABETOLOGIA
- Protective effects of hyperoside against human umbilical vein endothelial cell damage induced by hydrogen peroxide
- (2011) Zi-lin Li et al. JOURNAL OF ETHNOPHARMACOLOGY
- Oxidative Stress in Diabetic Nephropathy
- (2010) N. Kashihara et al. CURRENT MEDICINAL CHEMISTRY
- Pathologic Classification of Diabetic Nephropathy
- (2010) T. W. C. Tervaert et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mechanisms of Podocyte Injury in Diabetes: Role of Cytochrome P450 and NADPH Oxidases
- (2009) A. A. Eid et al. DIABETES
- Mouse Models of Diabetic Nephropathy
- (2009) F. C. Brosius et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species
- (2009) M. J. van den Hoven et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Abnormal Glomerular Permeability Characteristics in Diabetic Nephropathy: Implications for the therapeutic use of low-molecular weight heparin
- (2008) E. J. Lewis et al. DIABETES CARE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started